Robert Jacks Founder of Sparrow Pharmaceuticals Backed byU.S. Venture PartnersDafina TonchevaJacques Benkoski SourcesSparrow Pharmaceuticals Announces $95 Million Series B Financing to Advance Targeted Therapy for Type 2 Diabetes — 2025-09 Browse all founders · Browse investors
